BioSpace News Archive

Rapid advancements in genomic technology, increasing number of IVF procedures, and rising funds by public and private organizations to support diagnosis of genetic disorders are some key factors expected to drive global Reproductive Genetics market growth.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, announced today that it has opened patient enrollment in the Phase 1b clinical trial of PH-762 for the treatment of advanced melanoma.

Fervent Pharmaceuticals announced today that it has commenced its virtual clinical study to evaluate the effectiveness of its novel product for the treatment of the symptoms of moderate to severe hot flashes, night sweats and nighttime awakenings due to hot flashes.

The 2021 Annual report of Promore Pharma AB and all AGM related documents are now available on the Company’s website.

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases with high unmet needs, announced today that they have received a Study May Proceed Letter from the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical trial to investigate ARINA-1 in non-cystic fibrosis bronchiectasis (NCFBE).

Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, PerkinElmer.

Temedica announces the expansion of its expert advisory board, which provides strategic support for company growth, access to unique networks and acts as sparring partner.

The International Gaucher Alliance and Cerner Corporation announce that the GARDIAN registry is now open for registrations, and the first patient has already enrolled April 25, 2022.

Today, The European Society of Medicine published a study, sponsored by Dr. Ferrer BioPharma of Miami, containing game-changing data on how the world can effectively reduce the effects of COVID-19.